Search results for "Breslow thickne"

showing 10 items of 14 documents

Features associated with melanoma metastasis in Latvia

2020

Cutaneous melanoma (CM) is the most aggressive form of skin cancer, exhibits an increasing incidence worldwide and has a high potential to develop metastasis. The current study aimed to identify a set of parameters that may aid in predicting the probability and timing of the onset of CM metastasis. A retrospective analysis was performed using the archive data of 2,026 patients with CM that were treated at the Riga East University Hospital Latvian Oncology Centre, which is the largest oncological hospital in the country, between 1998 and 2015. A case-control study design was employed, where patients with metastasis (n=278) were used as the cases and patients without metastasis were used as t…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyRate ratiosurvivalMetastasisBreslow Thickness03 medical and health sciences0302 clinical medicinepigmentInternal medicinemelanomamedicinemetastasisbusiness.industryMelanomaCancerArticlesOdds ratiomedicine.diseaseulceration030104 developmental biologyOncology030220 oncology & carcinogenesisCutaneous melanomaprognosisSkin cancerbusinessBreslow thicknessOncology Letters
researchProduct

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas

2020

Several studies have focused on identifying microRNAs involved in the pathogenesis of melanoma. However, its association with clinicopathological features has been scarcely addressed. The aim of this study is to identify microRNAs expression profiles related to aggressive clinicopathological and molecular features, and to analyze the association with melanoma survival. A retrospective and observational study was performed in a series of 179 formalin-fixed paraffin embedded primary cutaneous melanomas. First, a screening analysis on a discovery set (n = 22) using miRNA gene chip array (Affymetrix, Santa Clara, California, USA) was performed. Differentially expressed microRNAs were detected e…

AdultMale0301 basic medicineCancer ResearchPoor prognosisSkin NeoplasmsTERT mutationsDermatologyBiologyPathogenesisBreslow Thickness03 medical and health sciences0302 clinical medicinemicroRNAmelanomamedicineHumansMelanomaMitosisSurvival analysisAgedMelanomaMicroRNA Expression ProfileMiddle AgedPrognosismedicine.diseasemicroRNAsMicroRNAs030104 developmental biologyOncology030220 oncology & carcinogenesisCancer researchFemaleprognosisclinicopathological featuresMelanoma Research
researchProduct

Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.

2000

BACKGROUND Making a morphologic distinction between benign and malignant melanocytic tumors of the skin is frequently difficult, especially because “gray zones” between these lesions often exist. DNA image cytometry as an adjuvant method for the diagnosis and prognostic prediction of premalignant lesions and malignant tumors of many other organs is already well established. The aim of this study was to determine whether DNA image cytometry is helpful in distinguishing benign from malignant melanocytic lesions and whether cytometry would give valid information with which to predict the prognoses associated with malignant melanomas. METHODS DNA image cytometry was performed on 127 benign and …

AdultMaleCancer ResearchPathologymedicine.medical_specialtySkin NeoplasmsStatistics as TopicVideo RecordingMalignant transformationBreslow ThicknessHutchinson's Melanotic FreckleNevus BlueNevus Epithelioid and Spindle CellmedicineHumansMelanomaNevusDNA Image CytometryImage CytometryRetrospective StudiesPloidiesbusiness.industryMelanomaCancerReproducibility of ResultsDNA NeoplasmMiddle Agedmedicine.diseaseAneuploidyPrognosisDiploidyHMB-45OncologyEvaluation Studies as TopicImage CytometryMelanocytesFemalebusinessCytometryDysplastic Nevus SyndromePrecancerous ConditionsFollow-Up StudiesForecastingCancer
researchProduct

Primary cutaneous melanoma in hidden sites is associated with thicker tumours — a study of 829 patients

2001

The aim of this study was to determine if primary cutaneous melanomas in hidden anatomical sites were associated with thicker tumours. Retrospective medical data of 829 patients with melanomas diagnosed at our centre between January 1976 and July 1998 were recorded from our database. Three groups were defined according to the anatomical site of the primary melanoma: (1) visible areas (group 1: 493 patients); (2) visible areas only to the patients or to their partners in privacy (group 2: 281 patients); and (3) hidden areas (group 3: 55 patients). Univariate analysis indicated that patients with melanoma in hidden regions presented significantly thicker tumours (median for group 3: 2.25 vers…

AdultMaleCancer Researchmedicine.medical_specialtySkin NeoplasmsMultivariate analysisAdolescentDiseaseBreslow ThicknessSex FactorsInternal medicinemedicineHumansMelanomaAgedNeoplasm StagingRetrospective StudiesAged 80 and overAnalysis of VarianceUnivariate analysisbusiness.industryMelanomaAge FactorsRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryAnatomical sitesOncologyCutaneous melanomaFemalebusinessEuropean Journal of Cancer
researchProduct

Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.

2020

CD4 T cells play a key role in anticancer immunity. In this study, we investigate the clinical relevance of circulating CD4 T helper type 1 (Th1) response against telomerase (anti-TERT Th1 response) in patients with melanoma. The spontaneous anti-TERT Th1 response was detected in 54.5% (85/156) of patients with melanoma before treatment. The prevalence of this systemic response was inversely related to Breslow thickness >1 mm and American Joint Committee on Cancer stage ≥II (P = 0.001 and 0.032, respectively). In contrast to patients treated with targeted therapies, the anti-TERT Th1 immunity was associated with an objective response after immune checkpoint inhibitors treatment. Hence, 86% …

AdultMaleTelomeraseSkin Neoplasmsmedicine.medical_treatmentDermatologyBiochemistryBreslow ThicknessImmunitymedicineHumansTelomerase reverse transcriptaseProgression-free survivalProspective StudiesMolecular BiologyImmune Checkpoint InhibitorsMelanomaTelomeraseAgedNeoplasm Stagingbusiness.industryMelanomaCell BiologyImmunotherapyMiddle AgedTh1 Cellsmedicine.diseaseProgression-Free SurvivalDrug Resistance NeoplasmCancer researchBiomarker (medicine)FemalebusinessFollow-Up StudiesThe Journal of investigative dermatology
researchProduct

Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.

2006

Epidemiological studies on cutaneous melanoma in Mediterranean countries are scarce. Our aim was to perform a descriptive analysis of melanoma cases diagnosed in Valencia, Spain, and to evaluate the relationship between Breslow thickness and some clinical features. A total of 1571 patients with histologically confirmed cutaneous malignant melanoma diagnosed at the two main referral melanoma centres were evaluated retrospectively. For each patient the following clinical and pathological characteristics were selected: age, gender, anatomic site, histogenetic type, Breslow thickness, presence of ulceration, the stage, and symptoms such as bleeding, changes in size and colour, altered sensation…

AdultMalemedicine.medical_specialtyPathologySkin NeoplasmsHemorrhageDermatologyLogistic regressionBreslow ThicknessSex FactorsEpidemiologymedicineHumansStage (cooking)PathologicalMelanomaAgedRetrospective StudiesAged 80 and overbusiness.industryFootMelanomaAge FactorsAnatomical pathologyGeneral MedicineMiddle Agedmedicine.diseaseHandDermatologyLogistic ModelsSpainLymphatic MetastasisCutaneous melanomaMultivariate AnalysisSensation DisordersFemalebusinessActa dermato-venereologica
researchProduct

Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial o…

2014

Summary Background Even though progress has been made, the detection of melanoma still poses a challenge. In light of this situation, the Nevisense electrical impedance spectroscopy (EIS) system (SciBase AB, Stockholm, Sweden) was designed and shown to have the potential to be used as an adjunct diagnostic tool for melanoma detection. Objectives To assess the effectiveness and safety of the Nevisense system in the distinction of benign lesions of the skin from melanoma with electrical impedance spectroscopy. Methods This multicentre, prospective, and blinded clinical study was conducted at five American and 17 European investigational sites. All eligible skin lesions in the study were exami…

AdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentMedizinDermoscopyDermatologySensitivity and SpecificityBreslow ThicknessYoung AdultPositive predicative valueBiopsymedicineElectric ImpedancePhotographyHumansddc:610Prospective StudiesProspective cohort studyMelanomaEarly Detection of CancerAgedAged 80 and overmedicine.diagnostic_testbusiness.industryMelanomaOriginal ArticlesMiddle Agedmedicine.diseaseDermatologySurgeryClinical trialCarcinoma Basal CellDielectric SpectroscopyCutaneous melanomaCarcinoma Squamous CellFemalePatient SafetySkin cancerbusinessThe British journal of dermatology
researchProduct

A systematic review on external ear melanoma

2014

Summary Background External ear melanoma accounts for only 1% of all cutaneous melanomas, and data on its optimal management and prognosis are limited. Aim We aim to review the literature on external ear melanoma to guide surgeons in the treatment of this uncommon and peculiar pathology. Materials and methods A systematic review of English language studies on ear melanoma published from 1993 to 2013 was performed using the PubMed electronic database. Data on epidemiology, oncological treatment (tumor resection and regional lymph nodes management), and reconstruction were extrapolated from selected papers. Results The total number of patients was 858 (30 studies). The helix was the most comm…

External earmedicine.medical_specialtySkin NeoplasmsPrognosiSentinel lymph nodeSettore MED/19 - Chirurgia PlasticaSurgical FlapsBreslow ThicknessEpidemiologyBiopsymedicineHumansReconstructive Surgical ProcedureSkin NeoplasmStage (cooking)Ear ExternalMelanomaEar NeoplasmsNeoplasm Stagingmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaLymphatic MetastasiPlastic Surgery Proceduresmedicine.diseasePrognosisOptimal managementSuperficial spreading melanomaSurgeryEar NeoplasmSurgical FlapLymphatic MetastasisSurgeryNeoplasm Recurrence LocalbusinessEar melanomaMelanoma treatmentHuman
researchProduct

Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases

2019

Background: The indication to sentinel node biopsy (SNB) for thin melanomas (Breslow <1 mm) is still subject to controversies. The aim of this paper is to review all SNB performed for thin melanoma and to analyze factors related to lymphatic metastasis. Moreover, the diagnostic performance of the 5th, 6th, 7th and 8th AJCC classifications for cutaneous melanoma were investigated. Methods: All sentinel node biopsies performed for thin melanomas were selected from a multicentre prospectively-collected database. For each patient the following was collected: age, sex, date of treatment, site of primary melanoma, histopathologic features (Breslow, Clark, number of mitoses/mm2 , presence of ul…

Malemedicine.medical_specialtySkin NeoplasmsMultivariate analysisRisk AssessmentBreslow Thickness03 medical and health sciencesMelanoma; Sentinel node; Sentinel node biopsy; Thin melanoma0302 clinical medicineRisk FactorsBiopsyHumansMedicineProspective Studies030212 general & internal medicineSkin NeoplasmRisk factorProspective cohort studyMelanomaThin melanomaSentinel node biopsyMelanoma; Sentinel node; Sentinel node biopsy; Thin melanoma; Surgery; Oncologymedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaRisk FactorLymphatic MetastasiGeneral MedicineSentinel nodeMiddle Agedmedicine.diseaseProspective StudieOncologySentinel nodeLymphatic Metastasis030220 oncology & carcinogenesisCutaneous melanomaSurgeryFemaleRadiologybusinessHuman
researchProduct

A Brief Synopsis on Scalp Melanoma

2020

Melanoma constitutes one of the most sinister and troublesome malignancies encountered by humanity. Generally, the diagnosis of advanced melanoma connotes a grave prognosis, prompting a sense of looming threat of death, however, the early-stage detected disease responds well to robust treatment resulting in reasonable survivorship. Scalp melanomas are even more troublesome, because they typically exhibit more aggressive biologic behavior and are often diagnosed at a late stage. This review tries to comprehensively highlight the various diagnostic, therapeutic, and outcome aspects of scalp melanomas. The literature research includes peer-reviewed articles (clinical trials or scientific revie…

Melanomasmedicine.medical_specialtySkin NeoplasmsMEDLINEDermatologyEnglish languageDiseaseBreslow thickness; head and neck melanomas; melanomas; scalp melanomas; skin malignancies; Humans; Prognosis; Scalp; Head and Neck Neoplasms; Melanoma; Skin NeoplasmsBreslow thickne030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansMelanomaScalp melanomaAdvanced melanomaScalpHead and neck melanomabusiness.industryMelanomaLate stageHead and neck melanomasGeneral MedicinePrognosismedicine.diseaseDermatologyBreslow thickness; Head and neck melanomas; Melanomas; Scalp melanomas; Skin malignanciesClinical trialmedicine.anatomical_structureScalp melanomasHead and Neck NeoplasmsSkin malignancies030220 oncology & carcinogenesisScalpbusinessBreslow thickness
researchProduct